Pan-cancer analysis reveals MTTP as a prognostic and immunotherapeutic biomarker in human tumors
Our pan-cancer study emphasizes that MTTP is a promising prognostic and immunotherapeutic biomarker in tumors. High expression of MTTP is correlated with the infiltration of diverse immune cells and regulates ferroptosis in GC cells, providing a potential target for tumor immunotherapy.
Authors
- Yaping Gao (ORCID: https://orcid.org/0000-0001-5202-4205)
- Yanru Qin (ORCID: https://orcid.org/0000-0003-2175-9617)
- Yongxu Jia
- Wenjia Wang (ORCID: https://orcid.org/0000-0002-5502-462X)
- Jiayao Xu (ORCID: https://orcid.org/0009-0003-8849-9407)
- Yihan Liu (ORCID: https://orcid.org/0000-0001-9094-0693)
- Liwei Qin
- Xia Songbai
Institutions
- First Affiliated Hospital of Zhengzhou University (CN)
Publication Details
- Journal
- Frontiers in Immunology
- Published
- 2025-03-27
- DOI
- https://doi.org/10.3389/fimmu.2025.1549965
- Citations
- 4
- Primary Topic
- Cancer, Lipids, and Metabolism
- Type
- article
- Field-Weighted Citation Impact
- 3.75